Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Tigress Financial Maintains Buy on Square, Raises Price Target to $310

Tigress Financial analyst Ivan Feinseth maintains Square (NYSE:SQ) with a Buy and raises the price target from $295 to $310.

byBenzinga Newsdesk

November 17, 2021

1 minute read

Tigress Financial analyst Ivan Feinseth maintains Square (NYSE:SQ) with a Buy and raises the price target from $295 to $310.

NESR Secures Multiple Contract Awards Across Several Drilling & Evaluation For More Than $150M

By Benzinga Newsdesk

Today, 9:51 AM

National Energy Services Reunited Corp. ("NESR") (NASDAQ:NESR)(NASDAQ:NESRW), a national, industry-leading provider of integrated energy services in the Middle East and North Africa ("MENA") region,

NESR

RedHill Biopharma To Test Its Oral Antiviral In COVID-19 Patients In South Africa

By Vandana Singh

Today, 9:51 AM

Regulatory authorities in South Africa have signed off RedHill Biopharma Ltd’s (NASDAQ:RDHL) Phase 2/3 study evaluating RHB-107 (upamostat) for non-hospitalized patients…

RDHL

Atlantic Equities Upgrades McDonald’s For Proving Its Resilience Amid Economic Weakness

By Anusuya Lahiri

Today, 9:51 AM

Atlantic Equities analyst Edward Lewis upgraded McDonald’s Corp (NYSE:MCD) from Neutral to Overweight and raised the price target from $245 to $278. Lewis…

MCD

KetaDASH Announces Mobile Ketamine Treatments in San Francisco and Sacramento Area

By Nicolas Jose Rodriguez

Today, 9:51 AM

Ehave, Inc.

EHVVF

Tigress Financial Maintains Buy on Square, Raises Price Target to $310

Related Posts

NESR Secures Multiple Contract Awards Across Several Drilling & Evaluation For More Than $150M

RedHill Biopharma To Test Its Oral Antiviral In COVID-19 Patients In South Africa

Atlantic Equities Upgrades McDonald’s For Proving Its Resilience Amid Economic Weakness

KetaDASH Announces Mobile Ketamine Treatments in San Francisco and Sacramento Area